Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer

Por Thapar, Roopa, Titus, Mark A
Publicado no Curr Metabolomics (2014)

The Prolyl Isomerase Pin1 Regulates mRNA Levels of Genes with Short Half-Lives by Targeting Specific RNA Binding Proteins

Por Krishnan, Nithya, Titus, Mark A., Thapar, Roopa
Publicado em 2014

Potential prostate cancer drug target: Bioactivation of androstanediol by conversion to dihydrotestosterone

Por Mohler, James L., Titus, Mark A., Wilson, Elizabeth M.
Publicado em 2011

Atmospheric Pressure Photoionization Tandem Mass Spectrometry of Androgens in Prostate Cancer

Por Lih, Fred Bjørn, Titus, Mark A., Mohler, James L., Tomer, Kenneth B.
Publicado em 2010

Androgenic Biomarker Profiling in Human Matrices and Cell Culture Samples Using High Through put, Electrospray Tandem Mass Spectrometry

Por Wilton, John H., Titus, Mark A., Efstathiou, Eleni, Fetterly, Gerald J., Mohler, James L.
Publicado no Prostate (2014)

Thioredoxin Reductase 1 Expression and Castration-recurrent Growth of Prostate Cancer

Por Singh, Swaroop S, Li, Yun, Ford, Oscar Harris, Wrzosek, Carol S, Mehedint, Diana C, Titus, Mark A, Mohler, James L
Publicado em 2008

Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation

Por Saxena, Neeraj K., Titus, Mark A., Ding, Xiaokun, Floyd, Jeffrey, Srinivasan, Shanthi, Sitaraman, Shanthi V., Anania, Frank A.
Publicado em 2004

5α-ReductaseType 3 Enzyme in Benign and Malignant Prostate

Por Titus, Mark A., Li, Yun, Kozyreva, Olga G., Maher, Varun, Godoy, Alejandro, Smith, Gary J., Mohler, James L.
Publicado em 2013

5α-Reductase Type 3 Expression in Human Benign and Malignant Tissues: A Comparative Analysis During Prostate Cancer Progression

Por Godoy, Alejandro, Kawinski, Elzbieta, Li, Yun, Oka, Daizo, Alexiev, Borislav, Azzouni, Faris, Titus, Mark A., Mohler, James L.
Publicado no Prostate (2010)

Activation of the Androgen Receptor by Intratumoral Bioconversion of Androstanediol to Dihydrotestosterone in Prostate Cancer

Por Mohler, James L., Titus, Mark A., Bai, Suxia, Kennerley, Brian J., Lih, Fred B., Tomer, Kenneth B., Wilson, Elizabeth M.
Publicado em 2011

Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent Prostate Cancer

Por Titus, Mark A., Zeithaml, Brian, Kantor, Boris, Li, Xiangping, Haack, Karin, Moore, Dominic T., Wilson, Elizabeth M., Mohler, James L., Kafri, Tal
Publicado em 2012

14-3-3η Amplifies Androgen Receptor Actions in Prostate Cancer

Por Titus, Mark A., Tan, Jiann-an, Gregory, Christopher W., Ford, O. Harris, Subramanian, Romesh R., Fu, Haian, Wilson, Elizabeth M., Mohler, James L., French, Frank S.
Publicado em 2009

Mechanism of Androgen Receptor Corepression by CKβBP2/CRIF1, a Multifunctional Transcription Factor Coregulator Expressed in Prostate Cancer

Por Tan, Jiann-an, Bai, Suxia, Grossman, Gail, Titus, Mark A., Ford, O. Harris, Pop, Elena A., Smith, Gary J., Mohler, James L., Wilson, Elizabeth M., French, Frank S.
Publicado em 2013

Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer

Por Maity, Sankar N., Titus, Mark A., Gyftaki, Revekka, Wu, Guanglin, Lu, Jing-Fang, Ramachandran, S., Li-Ning-Tapia, Elsa M., Logothetis, Christopher J., Araujo, John C., Efstathiou, Eleni
Publicado no Sci Rep (2016)